Virtual Reality-Based Cognitive Behavior Therapy for Major Depressive Disorder: An Alternative to Pharmacotherapy for...

Area of Science:

• Mental Health
• Clinical Psychology
• Digital Therapeutics

Background:

• Cognitive behavioral therapy (CBT) is a recognized treatment for depression and suicidality.
• Virtual reality (VR) is utilized for cognitive training but less explored for depressive disorders.
• Effectiveness and safety of VR-based CBT for depression require further investigation.

Purpose of the Study:

• To evaluate the effectiveness and safety of a VR-based CBT program for major depressive disorder.
• To compare VR-based CBT with standard pharmacotherapy (treat as usual - TAU).
• To assess impact on depressive symptoms, suicidality, and clinical severity.

Main Methods:

• A multi-center, randomized, controlled exploratory trial involving 57 participants.
• Two groups: VR treatment group and TAU group (pharmacotherapy).
• Assessments at baseline, post-treatment (6 weeks), and 4-week follow-up.

Main Results:

• Depression scores decreased in both VR and TAU groups without significant differences.
• Suicidality scores significantly decreased only in the VR treatment group.
• No significant group differences in depression remission, response rates, perceived stress, or clinical severity. No adverse events reported.

Conclusions:

• VR-based CBT demonstrated potential equivalence to pharmacotherapy in reducing depressive symptoms.
• VR-based CBT showed a significant reduction in suicidality, unlike pharmacotherapy in this study.
• VR-based CBT may serve as a viable alternative treatment for major depressive disorder.